ABCA16 Inhibitors

Chemical inhibitors of ATP-binding cassette, sub-family A member 16 (ABCA16) offer diverse mechanisms to impede its function, primarily by interfering with its ATPase activity and substrate transport capabilities. Verapamil, a well-known calcium channel blocker, also reveals its ability to inhibit the ATPase activity of ABCA16, which is essential for the energy-dependent transport of substrates across membranes. Similarly, quercetin, a flavonoid with a broad spectrum of biological activities, targets the nucleotide-binding domain of ABCA16, preventing the crucial ATP hydrolysis step required for the protein's transport function. Elacridar and tariquidar, both potent inhibitors, exert their effects differently; elacridar alters the conformation of ABCA16, inhibiting substrate transport non-competitively, while tariquidar binds to allosteric sites, impeding ATPase activity and, thus, transport function.

Further expanding the arsenal of inhibitors, zosuquidar and laniquidar directly inhibit ABCA16 by binding to its nucleotide-binding domain and transmembrane domains, respectively, each leading to a blockade of ATP hydrolysis and substrate translocation. Reserpine takes a different approach by inhibiting the initial substrate binding to ABCA16, a necessary step for substrate transport. Progesterone, though a hormone, can bind to regulatory sites of ABCA16 and reduce its ATPase activity, demonstrating how endogenous compounds can influence the function of transport proteins. Moreover, cyclosporine A and glibenclamide exert their inhibitory effects by binding to the ATP-binding domain of ABCA16, preventing ATP from binding and thereby halting the transport cycle of the protein. Lastly, rifampicin selectively binds to ABCA16 and disrupts its normal transport cycle, showcasing a molecular interaction that impairs the protein's transport efficiency without affecting protein expression or cellular ATP levels. These chemicals elucidate the intricate control mechanisms governing ABCA16's activity and present a spectrum of molecular interactions through which this protein's function can be inhibited.